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To define the prevalence and fate of residual shunts after Gianturco coil oc-
clusion of patent ductus arteriosus (PDA), 50 pts were followed prospec-
tively after PDA coil occlusion at CS Mott Children's Hospital between 10/92
and 8/94. Evidence of residual shunt was sought on immediate post-coil aor-
tic angiograms and on color-flow Doppler echocardiograms performed in
follow-up. Survival analysis of residual PDA shunting was analyzed by the
Kaplan-Meier method, and the effect of minimum PDA angiographic size on
residual shunting was determined by ANOVA. The 50 pts, median age 4.4
years (range 0.4-621, have been followed for ~20 months (mean ± SD: 8 ±
6). PDA minimum diameter was 1.6 ± 0.8 mm (range 0.5--3.3). Complete PDA
occlusion was noted immediately in 29 pts (58%); tiny residual shunts closed
spontaneously 1-20 months after coil occlusion in 12 pts (24%). Tiny resid-
ual shunts persisted have undergone a second coil occlusion with immediate
complete closure. Survival analysis (graph) estimates 20 month prevalence
of residual shunts at 7 ± 6% after 1 coil procedure and 4 ± 4% after all coil
procedures. PDA diameter significantly influenced residual shunting, being
1.3 ± 0.7 mm in pts with immediate closure, 1.9 ± 0.8 mm with spontaneous
shunt closure in follow-up, and 2.0 ± 0.9 mm with persistent residual shunt
or second coil placement (p = 0.02).
trial, 40 patients received the dilatable banding prosthesis. Banding was suc-
cessful and uncomplicated. No migration of the prosthesis occurred. In only
1 patient was the band adjusted too tightly at implantation. The device was
never adjusted too loosely. There were 11 deaths. None were related to the
prosthesis. Dilatation was performed on 7 patients. This was successful in
6 and uncomplicated in all except 1 who developed a transient heart block.
The dilatable band prosthesis was explanted readily and completely in all
27 patients during their definitive surgery. In 7 patients stenosis of a pul-
monary artery branch developed as a result of distal implantation of the de-
vice. Balloon dilatation improved the stenosis in 2 of the patients. Surgical
pulmonary artery angioplasty was performed mn all 15 patients having to-
tal correction (TC) and in 4 of the 12 patients who had a bidirectional Glenn
procedure (BDGP) and Damus-Kaye-Stanzel connection (DKSC). The duration
of banding of the patients who had (TC) was 31 to 1139 (mean 339) days.
The duration of banding of the patients who had BDGP and DKSC was 88 to
594 (mean 215) days. The longest period of banding was 1640 days. Macro-
scopic and radiographic examination of all 28 explanted devices revealed no
evidence of wear or damage. Scanning electron microscopic examination
was conducted on 5 of the explanted devices which had been implanted
159 to 1139 (mean 422) days. One of the 5 had been successfully dilated.
No component failure was identified. The materials remained inert.
Conclusion: The dilatable band prosthesis is as safe and effective to use
as the conventional fixed fabric band. It is more readily explanted completely
and provides a safe non-surgical option for dilatation.
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Follow-up After Coil Occlusion of Patent Ductus
Arteriosus
David Shim, Raymond T. Fedderly, Robert H. Beekman, Achi Ludomirsky, Mary
L. Young, M. Anthony Schork, Thomas R. lloyd. C.S. Matt Children's Hospital, The
University of Michigan. Ann Arbor, MI
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Acute myocardial infarction (AMI) patients with an infarct related artery (IRA)
containing thrombus are a high risk group for percutaneous transluminal
coronary angioplasty. TEC may be a useful device for treatment of these
patients due to its ability to aspirate thrombus. TEC was prospectively eval-
uated in 63 patients (age 61 ± 12 years) including 23 (36.5%) ineligible for
thrombolysis, 24 (38%) with lytic failure, and 16 (25.5%) with post infarct
angina and a thrombotic coronary occlusion. Immediate, one week, and six
month angiographic and clinical followup were obtained. The IRA was a SVG
in 18 (29%) and a native coronary artery (NAT) in 45 (71 %). Acute procedu-
ral success with a residual stenosis <50% and TIMI 2 or 3 grade flow was
acheived in 94% of patients. There were no major procedural complications.
Other events during the hospitalization included death in 3 (4.8%), CABG in
2 (3%) and blood transfusion in 12 (19%). Elective predischarge angiography
revealed an IRA stenosis <50% in 34/38 (89%). Patients were followed for 6
months with clinical followup in 100% and angiographic in 38/63.
Angiographic restenosis occurred in 27/38 (71 %) although most pa-
tients returned for followup cath secondary to symptom recurrence. Clinical
restenosis occurred in 22 (42%).
Conclusions: High risk AMI patients can be successfully treated with TEC
with a high technical success rate and a low incidence of complications.
IRA patency at 1 week and 6 months was excellent; however, angiographic
restenosis remains a problem. Extraction of thrombus in AMI may help main-
tain vessel patency but does not appear to prevent restenosis.
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Conclusion: Although a larger lumen was obtained with PSS and DCA, this
was not associated with a significant reduction in revascularization, recurrent
angina or death at six months. Event free survival curves reveal overlapping
and low event free survival at 3 years.
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Dilatable Prosthesis for Banding the Main Pulmonary
Artery in Children Human Clinical Trials
Dennis J. Vince, Jacques G. LeBlanc, Gordon JA Culham, Glenn P Taylor
University of British Columbia. Vancouver; British Columbia, Canada
The objective of this trial is to test the hypothesis that a prosthesis of this
design can be dilated with an intraluminal balloon dilator and is as safe and
effective to use as the conventional fixed fabric band. The design of this
trial is that of a unicenter non-randomized prospective human clinical trial.
The controls are historical. The indications for banding and the surgical tech-
niques for implantation are those previously described and accepted for con-
ventional fixed fabric bands. Dilatation employed techniques described and
accepted for balloon pulmonary valvuloplasty. During the 57 months of this
Conclusions: 1) Survival analysis estimates 93% complete PDA closure af-
ter a single coil occlusion procedure; 2) Residual shunts are associated with
larger PDA diameter, and most close spontaneously; and 3) When necessary,
a second coil occlusion has been uniformly successful.
